September 26, 2017


Amy Schulman

Pfizer veteran AMY SCHULMAN has big pharma experience, but in Boston she discovered
her startup side. In 2014, she moved to Boston and joined Polaris Partners
as a venture partner and became CEO of Arsia Therapeutics. Arsia was acquired
in 2016, and Schulman is now CEO of drug-delivery startup Lyndra. She also teaches
leadership and corporate accountability at Harvard Business School. Schulman spoke with Xconomy
about adjusting to life in Boston biotech.

Amy Schulman, Lyndra • Photography by Alex Gagne and Rythum Vinoben